Minjun Dong

Sir Run Run Shaw Hospital, 3 East Qingchun Road
Hangzhou, 310016, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Multicohort Construction, Immune Landscape Analysis, and PCOLCE2 Functional Validation of an Inflammation-Related Prognostic Model in Colorectal Cancer.

Multicohort Construction, Immune Landscape Analysis, and PCOLCE2 Functional Validation of an Inflammation-Related Prognostic Model in Colorectal Cancer.

Journal: BioFactors (Oxford, England)
Published: April 07, 2026

Modulating apoptosis as a novel therapeutic strategy against Respiratory Syncytial Virus infection: insights from Rotenone.

Modulating apoptosis as a novel therapeutic strategy against Respiratory Syncytial Virus infection: insights from Rotenone.

Journal: Antiviral research
Published: May 23, 2024

HPVTIMER: A shiny web application for tumor immune estimation in human papillomavirus-associated cancers.

HPVTIMER: A shiny web application for tumor immune estimation in human papillomavirus-associated cancers.

Journal: iMeta
Published: May 03, 2023

Analysis of neoadjuvant chemotherapy for breast cancer: a 20-year retrospective analysis of patients of a single institution.

Analysis of neoadjuvant chemotherapy for breast cancer: a 20-year retrospective analysis of patients of a single institution.

Journal: BMC cancer
Published: January 30, 2023

Immune landscape and risk prediction based on pyroptosis-related molecular subtypes in triple-negative breast cancer.

Immune landscape and risk prediction based on pyroptosis-related molecular subtypes in triple-negative breast cancer.

Journal: Frontiers in immunology
Published: July 08, 2022

Corrigendum: STAT5a Confers Doxorubicin Resistance to Breast Cancer by Regulating ABCB1.

Corrigendum: STAT5a Confers Doxorubicin Resistance to Breast Cancer by Regulating ABCB1.

Journal: Frontiers in oncology
Published: February 21, 2022

STAT5a Confers Doxorubicin Resistance to Breast Cancer by Regulating ABCB1.

STAT5a Confers Doxorubicin Resistance to Breast Cancer by Regulating ABCB1.

Journal: Frontiers in oncology
Published: April 20, 2021

Establishment and Characterization of a HER2-Positive Cell Line Derived From the Pleural Effusion of a Drug-Resistant Breast Cancer Patient.

Establishment and Characterization of a HER2-Positive Cell Line Derived From the Pleural Effusion of a Drug-Resistant Breast Cancer Patient.

Journal: Frontiers in cell and developmental biology
Published: March 15, 2021

Evaluation of the diagnostic value of circulating tumor cells with CytoSorter® CTC capture system in patients with breast cancer.

Evaluation of the diagnostic value of circulating tumor cells with CytoSorter® CTC capture system in patients with breast cancer.

Journal: Cancer medicine
Published: June 05, 2019

Comparable efficacy and less toxicity of pegylated liposomal doxorubicin versus epirubicin for neoadjuvant chemotherapy of breast cancer: a case-control study.

Comparable efficacy and less toxicity of pegylated liposomal doxorubicin versus epirubicin for neoadjuvant chemotherapy of breast cancer: a case-control study.

Journal: OncoTargets and therapy
Published: August 09, 2018

Lin28 mediates paclitaxel resistance by modulating p21, Rb and Let-7a miRNA in breast cancer cells.

Lin28 mediates paclitaxel resistance by modulating p21, Rb and Let-7a miRNA in breast cancer cells.

Journal: PloS one
Published: January 30, 2012
Showing 1-11 of 11

Last Updated: 09/26/2026